Synektik Spólka Akcyjna: Business Overview, Financials & Competitive Analysis
Synektik Spólka Akcyjna scores 7/10 on the AskCyborg Cyborg Score (Solid). Synektik represents a profitable, dividend-paying niche player in Central European medical imaging with strong returns and cash generation, offering stable value exposure in a consolidating healthcare technology market. Synektik demonstrates solid operational performance with strong profitability metrics (18.33% operating margin), excellent returns on equity, and positive market momentum (39.58%.
What is Synektik Spólka Akcyjna's industry? Synektik Spólka Akcyjna (synektik.com.pl) operates in Medical Device Manufacturing & Healthcare IT Solutions. AskCyborg classifies Synektik Spólka Akcyjna under Medical Device Manufacturing & Healthcare IT Solutions in its company registry.
Synektik Spólka Akcyjna is a Polish medical technology company specializing in diagnostic imaging, nuclear medicine, and minimally invasive surgery solutions. The company operates as an integrated provider of medical ...
Cyborg Score thesis
Synektik represents a profitable, dividend-paying niche player in Central European medical imaging with strong returns and cash...
Read the full analyst-debate transcript →Get the Latest Synektik Spólka Akcyjna Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeSynektik Spólka Akcyjna Overview
Pro stress-test →Synektik Spólka Akcyjna is a Polish medical technology company specializing in diagnostic imaging, nuclear medicine, and minimally invasive surgery solutions. The company operates as an integrated provider of medical equipment, PACS software, radiopharmaceuticals, and comprehensive support services to healthcare facilities across Central Europe.
Strategic Profile
Pro stress-test →Synektik holds strategic advantages through its partnership with Siemens, its proprietary PACS software platform for diagnostic imaging laboratories, and its multi-country operational presence including Poland, Czech Republic, and Slovakia. The company benefits from strong financial metrics including a 51.78% ROE, solid cash generation with PLN 42.12 million in free cash flow, and a dividend yield of 4.18%, positioning it as a profitable, cash-generative healthcare solutions provider.
Competitive Landscape
Pro stress-test →Synektik operates in the fragmented Central European medical imaging and diagnostic equipment market, competing against larger multinational firms like Siemens (its partner), Philips, and GE Healthcare. Its competitive advantages lie in specialized PACS software, localized service infrastructure, and partnerships that larger competitors cannot efficiently replicate in smaller markets. The company occupies a defensible niche serving regional healthcare institutions that value integrated solutions and personalized support.
Industry Context
Synektik Spólka Akcyjna operates in Medical Device Manufacturing & Healthcare IT Solutions.
Key facts
Headquarters: Warsaw, Poland · Revenue: PLN 592.94M · Market cap: PLN 1.69B